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Abstract
Introduction:
Tight glycemic control (TGC) has shown benefits but has been difficult to implement. Model-based methods and 
computerized protocols offer the opportunity to improve TGC quality and compliance. This research presents 
an interface design to maximize compliance, minimize real and perceived clinical effort, and minimize error 
based on simple human factors and end user input.
Method:
The graphical user interface (GUI) design is presented by construction based on a series of simple, short 
design criteria based on fundamental human factors engineering and includes the use of user feedback and 
focus groups comprising nursing staff at Christchurch Hospital. The overall design maximizes ease of use 
and minimizes (unnecessary) interaction and use. It is coupled to a protocol that allows nurse staff to select 
measurement intervals and thus self-manage workload.
Results:
The overall GUI design is presented and requires only one data entry point per intervention cycle. The design 
and main interface are heavily focused on the nurse end users who are the predominant users, while additional 
detailed and longitudinal data, which are of interest to doctors guiding overall patient care, are available via 
tabs. This dichotomy of needs and interests based on the end user’s immediate focus and goals shows how 
interfaces must adapt to offer different information to multiple types of users.
Conclusions:
The interface is designed to minimize real and perceived clinical effort, and ongoing pilot trials have 
reported high levels of acceptance. The overall design principles, approach, and testing methods are based on 
fundamental human factors principles designed to reduce user effort and error and are readily generalizable.
J Diabetes Sci Technol 2012;6(1):125-134
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Introduction
Hyperglycemia and glycemic variability increase 
the risk of negative outcomes,1–3 as well as cost,4,5 in 
critical care. Tight glycemic control (TGC) can mitigate 
these issues.6–9 While consistent, effective TGC is 
elusive,10 computerized and model-based methods11–13 
have the potential to provide significant improvements. 
However, a computer-based system may also introduce 
additional sources of error, as well as increase workload 
through unnecessary or repetitive interactions with 
computer software.
This case study explores several aspects of user interface 
design in the clinical context of TGC. The goal is to 
maximize the potential benefits of a more complex, 
patient-specific system by minimizing the effort and error 
of interacting with the computer. The advantages of 
model-based systems to offer patient-specific therapy14–16 
can potentially be offset by data entry or noncompliance 
errors that increase resistance to adoption despite 
promising pilot trial results. Good interface design 
and ergonomics can minimize effort and error, thus 
improving the potential adoption and efficacy of the 
underlying protocol.
The current “human in the loop” approach for computerized 
protocols ensures safety and reduces regulatory issues. 
There is thus a range of interaction between technology, 
the protocol, and human behavior. These human factors 
can lead to problems that include:
• Poor/misentry of data or/and transcription errors,
• Poor/misentry of the control input suggested to 
insulin or nutrition pumps,
• Incomplete data entered or available, and
• Noncompliance with protocol interventions or 
measurement frequency.
All these errors can influence the performance of a 
computer-based TGC protocol.
Human–computer interaction is well studied in other 
fields and industries but is an emerging topic in medicine, 
which has its own unique application-specific features. 
Studies have described a link between real and perceived 
clinical effort and user interface.17 In TGC, issues that most 
affect compliance are quite often unrelated to the specific 
patient or treatment but are a function of protocol design 
and its ability to integrate into a given clinical setting.18,19 
Hence compliance has been problematic in TGC and can 
significantly affect results.11,20,21 Other human factors and 
objective feedback from protocol success or failure have 
also been noted.17,22–24 Thus, specific interface design and 
ergonomics of data entry and management are equally 
critical aspects of TGC protocol development.
This case study presents the design of a graphical user 
interface (GUI) for a new model-based and computerized 
TGC protocol [stochastic targeted (STAR)] being designed 
to replace a paper-based protocol [specialized relative 
insulin nutrition titration (SPRINT)]. The design presented 
is based on significant end user (nurse) input and 
feedback and thus focuses on minimizing unnecessary 
inputs and clinical effort to maximize ease of use 
and compliance.
Methods
Stochastic Targeted Tight Glycemic Control System
This GUI is designed for use with the glycemic control 
protocol STAR, a model-based and computerized control 
protocol that uses probabilistic methods14,15,25 to determine 
the optimum combination of dextrose (nutrition) and 
insulin administration to ensure tight control and 
safety from hypoglycemia in the presence of significant, 
clinically observed intrapatient and interpatient vari-
ability.26,27 A version of STAR is currently in use in Liege, 
Belgium.25 Nurses measure blood glucose (BG) manually 
at the bedside every 1–3 h (per the protocol) using a 
handheld glucometer and input this measurement into 
a computer. The model-based treatment suggests an 
insulin and nutrition intervention to maximize time 
in clinically specified glycemic bounds and a specified 
5% or lower hypoglycemic risk (BG < 4.4 mmol/liter). 
Nurses select the measurement interval to self-manage 
workload within the protocol.
Implementation System
A touch-screen tablet was selected as the implementation 
platform for STAR, primarily for size, portability, and 
hygiene reasons. The main design goals were minimal 
touches, minimal screens, and maximal default entry. 
The overall intent is to minimize user error and effort 
via a system that safely minimizes unnecessary inputs, 
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which was also part of end user feedback. These goals 
are designed to reduce risk of both entry error that can lead 
to inappropriate recommendations as well as the risk 
of misuse or noncompliance. Importantly, STAR itself 
limits the rate of change, as well as the maximum and 
minimum rates of insulin and nutrition administration, 
providing a significant level of safety from extreme 
recommendations.15,25 Thus, data entry methods (described 
elsewhere) and easy functional use by nurse staff were 
critical design elements.
Blood glucose data entry is done using a cash register 
method that explicitly avoids having to use the 
decimal button. This approach reduced uncorrected 
entry errors from 5–7% reported to less than 1%. All 
uncorrected errors resulted in extreme values so that 
automated data entry checking (e.g., BG < 2.0 mmol/liter 
or BG > 15.0–20.0 mmol/liter) would catch these entries 
and ask for confirmation.
Graphical User Interface Design and Operation
The final user interface design and basic operation were 
done using the results of several nurse and doctor focus 
groups that were held as open discussions during the 
break periods of each shift at the Christchurch intensive 
care unit (ICU). The actual design was based on these 
interviews and the testing of intermediate designs 
from which further input and feedback was obtained. 
Specific attention and input was obtained from the unit’s 
three nurse trainers and the senior nurses on each shift, 
as well as the senior consulting doctors.
Based on this feedback, the design goal was to minimize 
touches and unnecessary entry that increase the risk of 
error or unnecessary confirmation that increases (perceived) 
effort and can lead to potential noncompliance. A fast, 
easily used interface will encourage users not to “work 
around” the system. The resulting interface is presented 
“as constructed” along with initial nursing feedback.
Results and Graphical User Interface 
Design
The GUI design is presented by construction. The overall 
workflow and number of touches for typical use are 
presented graphically.
The GUI is designed so that the most important information 
is presented as clearly and unambiguously as possible. 
Screens display minimal wording to avoid clutter and 
ensure information is easy to find, as well as to avoid 
misreading. Infrequently used screens present detailed 
information for review (e.g., history) or give access to 
infrequent options. These screens are only available via 
tabs so that only interested users need see or use them.
This latter choice was made based on direct input from 
nurses who focused on running the protocol with 
minimal interruption or distraction. It ran counter to the 
desire of doctors to see more detailed long-term data to 
help them guide care. This dichotomy is critical to the 
design and indicates the significant differences between 
the end users (nurses) who apply the therapy and the 
end users (doctors) who guide overall patient care. Thus, 
the interface design focuses on the nurse end user who 
has the vast majority of contact with the system while 
providing different, more comprehensive information for 
the doctor end user.
The three main screens that the user interacts with are 
the main screen, the blood glucose entry screen, and 
treatment recommendation screen. They are shown in 
Figures 1–3.
The center of the main screen is a large display of the 
current (ongoing) treatment options, making it easy to 
read and interpret and check against pumps connected 
to the patient. The tabs at the bottom can be used to 
access more detailed information or treatment history. 
The buttons are large for easy use and minimal error 
on a touch screen. The upper right-hand corner has a 
counter (minutes) until the next scheduled measurement 
and intervention based on the nurse’s selection of 
intervention interval at the prior intervention. It thus 
provides the critical data of current therapy and time 
Figure 1. Graphical user interface main screen. The information 
displayed reflects the most recent set of BG control treatment data.
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until next action. Further longitudinal data and data detail 
are available via the tabs. Equally, for specific changes in 
therapy, the tabs offer access to customize care.
The BG entry screen has the cash register entry method. 
The buttons are large (Figure 2) for ease of use and to 
reduce errors and perceived effort. It is typically the 
only data entry required per intervention cycle. Hence, 
once patient data is input at the beginning of protocol 
use, effectively all data entry occurs only in this screen, 
unless unplanned changes are made to the treatment.
The treatment recommendation screen (Figure 3) is 
specific to the STAR protocol and presents a comparative 
summary of possible treatment options for 1, 2, and 3 h 
Figure 2. Blood glucose entry screen. Number entry is via the cash 
register method with automatic insertion of a decimal point. The user 
reads the measurement from the glucometer or blood gas analyzer 
and enters it and then presses “next.”
Figure 3. Treatment recommendation screen specific to STAR; it 
offers 1–3 h treatment intervals if possible. The nurse freely selects 
the interval to self-manage that aspect of clinical effort. If a certain 
interval is not available, it is not shown as an option. Colors match 
chart colors and syringe sticker colors used in the Christchurch ICU. 
Column 2 is highlighted as the selected option here.
intervals, all of which meet clinically set overall protocol 
targets.The information is in large text and color coded 
to aid in association with the same information on ICU 
charts and syringe labeling, which use similar colors. Large 
buttons allow the user to select the treatment option 
easily with minimal possibility of error. The user selects 
their desired option by touching the relevant “column” 
to select it and then pressing “finish.”
Regular Use
The flow of regular use in TGC is show in Figure 4. 
Each regular interaction requires two main steps: (1) input 
the latest BG value and (2) choose a recommended treatment. 
The GUI automatically reminds the user when a BG 
measurement is required, as shown in Figure 4 (step 2). 
Step 3 is the BG input. Up to three treatment options 
will be calculated by the STAR algorithm, depending on 
the safety of longer measurement intervals,14,15,25 and are 
displayed in step 4. The user will be asked to confirm 
the selected treatment (step 5) before returning to the 
main screen (shown as step 6).
Each of steps 1–5 in Figure 4 requires a single touch. 
Steps 2 and 5 are confirmatory entries and are the 
minimum number of confirmatory entries that was felt 
to be safe, based on consultation with clinicians and 
nursing staff. In particular, step 2 is a brightly colored 
visual (audible was not desired by nurses) alarm noting 
when a measurement was due. Note that the protocol 
accounts for any timing delay by noting the exact time 
of glucose entry in step 3, which starts the calculation 
process. Finally, the confirmation of step 5 offers the 
option to alter the (chosen) recommendation if desired.
In this GUI, EN and PN refer to parenteral and enteral 
nutrition, each of which has its own specific formulation. 
Equally, while STAR can vary nutrition as part of 
controlling glycemia, it may also be held at a constant 
value or shut off if clinically desired. The type of 
nutrition is specified on the nutrition tab and is part of 
starting a patient on STAR. Nutrition formulation and 
carbohydrate content are part of a drop-down menu 
showing all possible choices available in this ICU. It also 
includes formulation for 5% dextrose solutions and other 
common infusions.
Turning the Feed Off
Occasionally, the details of insulin and/or nutrition 
administration will need to be altered mid-treatment 
interval due to unforeseen circumstances. As an example, 
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Figure 4. Screen flow for a typical interaction to input a new measurement and calculate a new intervention.
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Figure 5. Screen flow for turning nutrition off, an atypical, extra intervention.
Figure 5 shows the process when altering nutrition inputs, 
which is only used if all clinical recommendations are 
overridden or if nutrition is changed/stopped for clinical 
reasons between measurements. 
To make changes to the current treatment, the user 
must first navigate to the relevant tab, in this case, the 
nutrition tab, shown in Figure 5 (step 1). Feed can then 
be switched off (for this example) using the button 
131
Interface Design and Human Factors Considerations for Model-Based  
Tight Glycemic Control in Critical Care Ward
www.journalofdst.orgJ Diabetes Sci Technol Vol 6, Issue 1, January 2012
highlighted in step 2. After informing the GUI whether 
feed must remain off (step 3), the user will input 
approximately how long ago the change occurred, which 
allows necessary changes to happen without any need 
to rush and update the controller, minimizing stress 
on staff and both real and perceived clinical burden.17,19 
The model-based STAR controller will then account for 
this change in the next intervention.
It is important to note that, if the change is significant and 
might lead to risk, the nurse has the choice to make a 
measurement and calculate a new intervention immediately. 
This is specified for STAR, for example, when stopping 
feed. However, it is not explicitly part of the GUI, as it 
was a clinical choice left to local practice and culture. 
Equally, one might choose only to use intervention 
periods of every 2 h despite being offered longer intervals, 
based on patient condition or local approach. Hence, 
this approach still maintains overall safety, but these 
choices are left to the local clinical staff and approach, 
rather than creating an overprescriptive approach. 
This choice was made, as with others, based on clinician 
and nurse feedback. Equally, further such advisories 
could also be added.
An entirely similar process occurs for stopping insulin 
infusions or missing an insulin bolus. They are accessed 
via the insulin tab in the main screen, but the process 
is otherwise essentially identical to ensure ease of use 
and to minimize errors. The process is also identical 
if insulin or nutrition rates are overridden or changed 
in the middle of an intervention interval, though they 
require an additional entry.
Discussion
Successful implementation of a clinical protocol is heavily 
dependent on human factors. Perceived effort can also 
have a major influence on compliance and clinical 
outcomes.17 By minimizing the number of screens and 
touches in a given interaction, the real and perceived 
time and effort required by nursing staff is reduced. 
It is important that the time taken and ease of use for 
this interface is comparable to, or better than, current 
successful paper-based protocols such as SPRINT.6,9 
In this regard, computerized systems offer default entry, 
which can minimize unnecessary data reentry and 
any resulting transcription errors. The trade-off is that 
this information still requires checking, and spurious 
default entries may be too easily ignored, turned off, or 
worked around.
Computerized medical decision support protocols have 
the potential to be more efficient than paper-based 
protocols in achieving compliance to protocol suggested 
interventions.11,28,29 Achieving a high level of compliance 
is vital to the success of a clinical protocol.20,21 Hence, 
the interface design and human factors are a critical link 
in developing successful TGC protocols.
The GUI was designed in an iterative process and is still 
subject to ongoing refinements as wider clinical pilot 
trials are ongoing. Changes were made based on feedback 
from clinical staff in focus groups that tested early 
designs. In initial designs, high importance was placed 
on the accuracy of data entry with information used for 
calculations requiring checking and confirmation prior 
to calculation. Although this initial process was linear 
and intuitive, it was time-consuming and frustrating to 
nurses, with previously entered data being correct in 
the vast majority of cases. Thus, while employing an 
entry checking process further increased the accuracy 
of data entered, the extra effort meant that compliance 
would be affected. In such case, users seek workarounds 
rather than using the system as designed, reducing 
efficacy of the protocol. Hence, a focus was made to 
ensure data entry accuracy (the benefits) without the 
need for checking (the real or perceived effort), which 
the methods selected have accomplished with minimal 
automated checking for safety.
Streamlining the user interaction process involves a 
trade-off between the burden of data entry and checking, 
the potential increase in risk, and introducing additional 
opportunities for error. Importantly, in this case, the 
potential for extra introduced error can be no worse than 
a paper-based protocol, which must assume that all 
instructions are being followed.
Removing the requirement of explicitly checking previous 
data means that any mid-intervention treatment changes 
need to be recorded by nurses on the computer. Instead 
of being prompted to enter the changed information, 
nurses need to use their initiative to input a treatment 
change into the GUI so that details are correct for the 
next calculation. Psychologically, this approach should 
empower users to own the use of the system, providing 
objective feedback17 and thus improving the quality of TGC.
Although entering changes in the middle of an 
intervention period is not difficult, it is easy to forget 
to enter these details immediately, as there are other, 
often more important, events in the ICU that nurses 
need to attend to. Therefore, allowances were made by 
132
Interface Design and Human Factors Considerations for Model-Based  
Tight Glycemic Control in Critical Care Ward
www.journalofdst.orgJ Diabetes Sci Technol Vol 6, Issue 1, January 2012
design to record changes at a later time and then specify 
when the change occurred to minimize interference, as 
the model-based controller only requires them when 
making calculations at intervention times. When times 
are not recorded accurately, there will be some effect 
on the accuracy of the model-based controller. However, 
any loss of accuracy is likely to be negligible compared 
with that introduced if the change was not recorded. 
The only exception is when enteral or parenteral 
nutrition administration is stopped, as leaving insulin 
infusions on after stopping feeding increases the risk 
of hypoglycemia.30
This latter requirement requires that a new BG value be 
measured and a new calculation be made in the system’s 
current form, although the GUI does not prescribe it 
explicitly, showing how a system such as this can be 
used within a clinical practice culture. In this case, that 
choice is left to clinical practice rather than prescribed 
by the GUI. This design choice leaves the current GUI 
design as a more flexible tool suitable to a wider range 
of clinical practices.
For acceptance by the nurse staff, STAR must be 
perceived as an improvement on the existing method 
(SPRINT in this case). Although reducing effort has been 
the focus of design, the nature of computerized protocols 
means that they are more complex and may be more 
time-consuming. However, computerized protocols are 
generally thought to reduce the perceived effort when 
compared with equivalent paper-based protocols.17 
Additionally, turnover of nursing staff in widespread 
clinical implementation means that training becomes 
a relevant issue. Pilot trials typically have extra staff 
and attention not available in everyday work practice. 
A system that is easy to use and easy to learn can 
significantly reduce the downtime associated with extra 
training, potentially reducing implementation costs and 
overall error rates as well.
Calculation times may also be a factor in perceived 
effort. The run time of calculations carried out by the 
controller directly influences the time taken to use the 
system. However, through improved control, fewer BG 
measurements may be required, and the fact that STAR 
will thus be used less overall may outweigh this increase 
in time taken for a given interaction. Currently, STAR 
requires on average 2–4 fewer measurements per day, 
saving a minimum of ~10–20 min of measurement effort 
alone,31 thus the calculation period of ~1–5 s or less is 
likely negligible.
One limitation of any design is that it is never complete. 
Examining Figure 4, the visual alarm of a page requesting 
a new BG measurement (panel 2) is not necessarily 
required. It could be eliminated, along with one touch, 
without loss of utility, by moving straight to the BG entry 
panel (panel 3). Further, such limitations and avenues for 
improvement may arise with ongoing use.
Point-of-care BG sensors that can upload measurements 
directly are currently available and seem one logical 
next step for computerizing TGC, as well as pumps that 
can stream data directly into a computer system. This much 
more automated data entry would remove much of 
the current potential for data entry errors, as well as 
remove a step from each interaction with the computer. 
However, regulatory issues and ensuring the fidelity 
of this transmission make this more complete level of 
automation problematic at this time.
Further, a computerized system offers many added 
possibilities not addressed in this design. In particular, 
a great deal more data entry could be included for 
other uses, such as tracking organ failure as a response 
to TGC,9 monitoring the impact of drug therapy,32 or 
using model-based metabolic markers in sepsis or other 
diagnostics.33,34 Such possible additions were not in the 
focus of this case study, but their addition or use could 
be included using a similar design approach.
However, specific additions that should be mentioned 
include the interface of this type of system to computerized 
patient records and pharmacy prescription records and 
the ability to better audit care decisions. The first case 
allows more streamlined data management and for 
that data to provide more insight to other doctors as a 
patient moves to less acute wards or settings, as well 
as enabling better logistics. The second illustrates how 
a computerized system can retain all that data to allow 
auditing of treatment selections, as well as patient or 
protocol performance over a ward or cohort.
In summary, this case study design has highlighted 
several fundamental design and human factors lessons 
that could be generalized to any interface design. They 
include the following:
•	 Minimize words and clutter, including the 
maximizing button sizes so they do not require 
specific dexterity (both will minimize user effort, 
error, and misuse);
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•	 Minimize the touches and interactions required to 
minimize error and effort;
•	 Minimize the data entry to minimize sources of 
unintended error, including the use of automated, 
rules-based data entry checking where appropriate;
•	 Minimize the error and effort of any data entry 
methods (via design and testing);
•	 Minimize the number of confirmations to minimize 
user effort and frustration;
•	 Use color coding to enhance ease and intuitiveness 
of use and thus minimize effort and error; and
•	 Do not underestimate the value of end user focus 
groups and feedback.
These lessons all focus on using design to minimize 
effort and error. The end result is a focus on simplicity 
that is often not fully addressed in device design.22–24
Conclusions
Poor interface design and/or complexity can result in 
significant errors in providing care in the ICU. This case 
study focuses on the user interface design and 
development for the new STAR control protocol, which 
has been designed to replace the less adaptable and 
flexible paper-based SPRINT in the Christchurch ICU. 
The GUI was designed using an iterative approach with 
changes made based on human factors principles and 
clinical feedback. The interface is designed to present 
information in a clear, concise manner that minimizes 
real and perceived user effort and to require a minimal 
amount of interaction and data entry. The resulting 
improvements should help to increase the compliance 
of the protocol and achieve better TGC and patient 
outcomes. More generally, the overall approach and 
methods for design are easily generalizable and can 
serve as a template for a more human-factors-centered 
approach to protocol interface design to best promote 
maximum compliance and minimum error.
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